OXB Insider Trading

Insider Ownership Percentage: 21.17%
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): GBX 0

Oxford Biomedica Insider Trading History Chart

This chart shows the insider buying and selling history at Oxford Biomedica by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
20222023202420250bought0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-10M-5M05M10MTotal Insider BuyingTotal Insider Selling

Oxford Biomedica Share Price & Price History

Current Price: GBX 405
Price Change: Price Decrease of -1.5 (-0.37%)
As of 01/20/2025 01:29 PM ET

This chart shows the closing price history over time for OXB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
FebMarAprMayJunJulAugSepOctNovDecJan405.00Closing price on 01/20/25:

Oxford Biomedica Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Oxford Biomedica (LON:OXB)

64.13% of Oxford Biomedica stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Oxford Biomedica logo
Oxford Biomedica (LSE: OXB) is a quality and innovation-led cell and gene therapy CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies. The Company collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise. Oxford Biomedica, a FTSE4Good constituent, is headquartered in Oxford, UK. It has locations across Oxfordshire, UK and near Boston, MA, US. Learn more at www.oxb.com and follow us on LinkedIn and YouTube.
Read More on Oxford Biomedica

Today's Range

Now: GBX 405
Low: 405
High: 409

50 Day Range

MA: GBX 419.64
Low: 392
High: 430

52 Week Range

Now: GBX 405
Low: 167
High: 450

Volume

102,621 shs

Average Volume

201,667 shs

Market Capitalization

£426.71 million

P/E Ratio

N/A

Dividend Yield

4.57%

Beta

1.09

Who are the company insiders with the largest holdings of Oxford Biomedica?

Oxford Biomedica's top insider investors include:
  1. Catherine Moukheibir (Insider)
  2. Dame Kay Davies (Insider)
  3. Michael Hayden (Insider)
  4. Roch Doliveux (Insider)
Learn More about top insider investors at Oxford Biomedica.